Rifampicin

• Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran… Pending
  2024-518018-22-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
• Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in… Pending
  2024-518350-17-00 Phase IV 1 country Vaestra Goetalandsregionen
• A randomised, prospective phase II study of pharmacokinetics and safety aspects of higher doses of rifampicin and pyrazinamide in a shortene… Pending
  2024-518772-32-00 Phase II 1 country Region Oestergoetland
• RIFAMAB : Rifabutin versus rifampicin, staphylococcal prosthetic joint infection, multicenter randomized, open-label, non-inferiority trial Pending
  2024-519894-20-01 Phase III 1 country Centre Hospitalier De Tourcoing
• Pragmatic trial on the safety and tolerability of an optimized dose of rifampicin in tuberculosis patients Recruiting
  2023-509885-39-00 Phase III 3 countries Stichting Radboud University Medical Center
• Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting
  2025-524484-20-00 Phase IV 1 country UZ Leuven
• The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting
  2025-522088-13-00 Phase IV 1 country Region Midtjylland
• AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-labe… Recruiting
  2023-506843-40-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
• Clindamycin for the treatment of infections: the influence of rifampicin and obesity on PK/PD target attainment Recruiting
  2024-515872-12-00 Phase IV 1 country UZ Leuven
• A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradeni… Recruiting
  2023-505818-16-00 Phase III 1 country Institut Pasteur
• Rifampicin at High Dose for Difficult-to-Treat Tuberculosis (RIAlta) study Recruiting
  2024-519983-42-00 Phase II 2 countries Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
• Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting
  2024-511719-40-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 Phase IV 1 country Rigshospitalet
• Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute Recruiting
  2022-502974-18-00 Phase II/III 1 country Centre Hospitalier Universitaire De Nice
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting
  2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
• Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting
  2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• The RiCOTTA study: Rifampicin Combination Therapy versus Targeted Antibiotic Monotherapy for Infected Joint Prostheses Caused by Staphylococ… Recruiting
  2022-501620-26-00 Phase IV 1 country Leiden University Medical Center
• Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) Recruiting
  2024-512759-19-00 Phase II 1 country Assistance Publique Hopitaux De Paris
• CLAZI : CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective co… Recruiting
  2024-518578-15-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
• Efficacy of dalbavancin in osteoarticular infections associated with hip, knee and shoulder prostheses PRO-DALBA Ended
  2024-518183-12-00 Phase II/III 1 country Centre Hospitalier Universitaire De Nice
• Comparison of three short rifamycin-based regimens to treat latent tuberculosis in patients with end-stage kidney disease. Ended
  2023-506432-32-00 Phase IV 1 country Bellvitge University Hospital; Fundacio Institut D'Investigacio Biomedica De Bel…
• RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BAS… Ended
  2023-509075-17-00 Phase II 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Showing 1–23 of 23 trials